Earnings Releases·Nov 13, 2026, 8:30 AM ET

BIO-key International, Inc. — Q3 2026 Earnings Summary

Q3 2026 total revenue declined 4% to $1.48M, driven by a shift to software-only orders, while license fee revenue surged 39% to $1.3M (86% of total revenue); gross margin improved to 90% and net loss narrowed 8% to $(886K) for the quarter.
The company achieved a 14% revenue increase to $5.5M for the first nine months of 2026 and narrowed the 9M net loss by 42% to $(1.7M), supported by a 39% growth in EMESA region revenue and the retirement of all remaining note payables.
Strategic capital activities included a warrant inducement generating $2.5M in proceeds and a 1-for-10 reverse stock split; however, a non-cash deemed dividend of $4.5M resulted in a reported net loss available to common stockholders of $(5.39M).
Management anticipates a strong finish to 2026 and 2027 growth fueled by new government wins in the Middle East, FIDO Alliance certification for AI agent authentication, and expanded partnerships with Cipher in Portugal and the U.S.